CN112375143A - Polyclonal antibody of pichia pastoris UGGT1 - Google Patents

Polyclonal antibody of pichia pastoris UGGT1 Download PDF

Info

Publication number
CN112375143A
CN112375143A CN202110020699.8A CN202110020699A CN112375143A CN 112375143 A CN112375143 A CN 112375143A CN 202110020699 A CN202110020699 A CN 202110020699A CN 112375143 A CN112375143 A CN 112375143A
Authority
CN
China
Prior art keywords
leu
uggt1
ile
asp
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110020699.8A
Other languages
Chinese (zh)
Inventor
王楠
杨彩峰
李刚强
郭文芳
彭华康
王梦琪
刘德虎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotechnology Research Institute of CAAS
Original Assignee
Biotechnology Research Institute of CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Research Institute of CAAS filed Critical Biotechnology Research Institute of CAAS
Priority to CN202110020699.8A priority Critical patent/CN112375143A/en
Publication of CN112375143A publication Critical patent/CN112375143A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961Plant cells or fungi
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35Valency
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts

Abstract

The invention discloses a polyclonal antibody of pichia pastoris UGGT 1. The invention clones pichia pastoris UGGT1 gene segments into escherichia coli, obtains pichia pastoris UGGT1 recombinant protein through IPTG induction expression, takes the recombinant protein as antigen to carry out animal immunity, obtains antiserum containing UGGT1 antibody, and the antiserum can be specifically combined with UGGT1 protein in yeast. The antibody provided by the invention can be applied to qualitative or quantitative determination of UGGT1 protein of pichia pastoris. The antibody prepared by the invention has high titer and strong specificity, and supports various experimental operations such as ELISA, Western-blot and the like.

Description

Polyclonal antibody of pichia pastoris UGGT1
Technical Field
The invention belongs to the technical field of genetic engineering antibodies, and particularly relates to a polyclonal antibody of pichia pastoris UGGT 1.
Background
UGGT1, which is localized to the Endoplasmic Reticulum (ER) of eukaryotes, is the only element currently found that can recognize the folded state of glycoproteins, and plays a central role in the glycoprotein amount monitoring system of eukaryotes. Because of its important biological functions, UGGT1 has been a hotspot in research fields such as eukaryotic glycoprotein synthesis, transport, metabolism and the like. In recent years, with the development of immunobiotechnology, ELISA, Western-blot, Co-IP, IF and the like have become conventional methods for protein research, and UGGT1 antibodies derived from different species have been generated, but the UGGT1 antigen of these antibodies has a large amino acid sequence difference, so that UGGT1 antibodies derived from different species cannot be used universally. At present, commercial UGGT1 antibody is mainly prepared by using animal and plant UGGT1 as an antigen, but the antibody capable of combining with yeast UGGT1 is still in the blank of the market, and no related literature report is found.
Pichia pastoris is an important industrial microorganism and is widely applied to the production of foreign proteins in the fields of food, medicine, feed and the like. As a foreign protein expression host, the protein has the specific post-translational modification function of eukaryote, can use cheap inorganic salt as a culture medium for high-density fermentation, has no toxic action on human and livestock by cells, and the like. However, pichia pastoris serving as a recombinant protein expression system still has some bottleneck problems to be broken through, for example, the expression quantity difference of different exogenous proteins is huge, the expression quantity of some proteins can reach more than gram level of fermentation liquor per liter, and the expression quantity of some proteins is as low as microgram level or even cannot be detected; in addition, when pichia pastoris expresses glycoprotein, excessive glycosylation is easy to occur, so that the function and the property of the recombinant glycoprotein are changed, and the problems are caused by that the research on the synthesis and metabolic mechanism of protein in pichia pastoris cells is not thorough and comprehensive at present.
In addition, pichia is also an important eukaryotic model organism, is a unicellular organism with eukaryotic organism characteristics, and is an excellent material for researching other higher eukaryotic organisms. The detailed analysis of the glycoprotein metabolic pathway is not only beneficial to solving the problems encountered by the industrial microorganism, but also beneficial to explaining the glycoprotein synthesis and metabolism mechanisms of other higher eukaryotes.
In eukaryotes, most proteins require post-translational modifications, such as N-glycosylation, O-glycosylation, acetylation, and formation of disulfide bonds, to perform specific biological functions. Among them, N-glycosylation is the most common and one of the most important post-translational modifications. A large number of researches show that N-glycosylation has obvious influence on the biological activity, the thermal stability, the signal recognition, the extracellular release and the like of the protein. In various eukaryotic cells, glycosylation of proteins has a complete and conserved molecular mechanism, which mainly includes (1) specific binding of Oligosaccharide chain Glc3Man9GlcNAc2 to Asn (Asn-Xxx-Ser/Thr, Xxx cannot be Pro) of N-glycosylation binding site of newly synthesized polypeptide under the action of Oligosaccharide transferase (OST), (2) rapid cleavage of terminal three glucoses of Oligosaccharide molecule bound by glycoprotein under the action of glucosidase i and glucosidase ii, reversible interaction of specific endoplasmic reticulum localization chaperone (cnx) or soluble chaperone calreticulin (crt) with glycoprotein having only 1 glucose at terminal, and protein folding under the help of other chaperones (e.g. peptidyl isomerase ERp57, prolyl isomerase CypB, etc.), (3) if the glycoprotein can successfully complete correct folding at this time, the glycoprotein is transported out of ER, enters a subsequent processing step, and is finally transported to a specific organelle or secreted out of the cell; if the glycoprotein does not complete the correct folding, UGGT1 located in the ER will recognize the misfolded glycoprotein and add 1 molecule of glucose back to the oligosaccharide chain, forming GlcMan9GlcNAc2, and be recognized again by the chaperone CNX/CRT, forming the CNX/CRT cycle. During the circulation, proteins that are not always able to form a correct fold will eventually enter the degradation pathway. This process is also called ER-related glycoprotein quantity monitoring system. During the processing of the above glycoproteins, UGGT1 is the only element that can identify the folded state of the glycoprotein, and is the core and rate-limiting element of the process. Due to the key role of UGGT1, studies on UGGT1 have always been a hotspot in the field of eukaryotic protein glycosylation studies.
Studies on UGGT1, focused primarily on animal cells and individual species of plants and yeast, and UGGT1 antibodies also played an important role in these studies, e.g., in mouse embryonic fibroblasts, the effect of misfolded glycoproteins on activation of the CNX/CRT cycle was revealed by identification of UGGT1 deletion mutants by UGGT1 antibodies (maurizoi moliari, 2005). Co-IP and IF experiments demonstrated that UGGT1 is able to promote RNA virus replication and exacerbate infection of human embryonic rhabdomyosarcoma cells by binding to enteroviruses (Peng-Nien Huang, 2017). UGGT1 was found to be essential for the maturation and secretion of pro-sphingolipid activator proteins in CHO cells by Co-IP and IF experiments (Bradley r. Pearse, 2009).
In conclusion, a large number of studies show that UGGT1 plays a very important biological function in cells, but in an important industrial microorganism of Pichia pastoris, the UGGT1 has a large molecular weight and a complex structure, and has no reports on the function and location of UGGT1 because of no available commercial antibody and difficulty in preparing the antibody in a laboratory and the like. The research of pichia pastoris UGGT1 is seriously lagged, and the research aspects such as glycoprotein synthesis and metabolic mechanism and the like do not exert the whole value as a model organism, so that a pichia pastoris UGGT1 antibody with good specificity and high titer is urgently needed to be developed to promote the research of pichia pastoris UGGT1, and further provide necessary experimental materials and technical support for perfecting a pichia pastoris recombinant expression system, expanding the industrial application range of pichia pastoris and exploring the high eukaryotic glycoprotein synthesis and metabolic mechanism.
Disclosure of Invention
The invention aims to provide a polyclonal antibody of pichia pastoris UGGT 1.
A polyclonal antibody of Pichia pastoris UGGT1 is prepared by taking the polypeptide of amino acid sequence at 1133-1430 th site of Pichia pastoris UGGT1 as antigen through animal immunization.
The antigen takes pichia pastoris UGGT1 amino acid sequence polypeptide at 1133-1430 th site as a core sequence, and a plurality of amino acid residues or a plurality of amino acid residues are added at two ends or one end of the core sequence.
The amino acid sequence of UGGT1 is shown in SEQ ID No: 1, the DNA sequence of UGGT1 gene is shown as SEQ ID No: 2, the sequence of the amino acid fragment 1133-1430 of the UGGT1 amplified by PCR is shown as SEQ ID No: 3, the corresponding 3397-4290bp DNA fragment has the sequence shown in SEQ ID No: 4, respectively.
A kit for detecting Pichia pastoris UGGT1 protein is characterized by comprising the polyclonal antibody.
An indirect sandwich ELISA detection kit of Pichia pastoris UGGT1 protein comprises Pichia pastoris UGGT1 standard protein, a washing solution, a confining solution, a substrate developing solution, a stopping solution, an ELISA plate coated with the polyclonal antibody, a detection antibody and an enzyme labeled antibody; the enzyme-labeled antibody is goat anti-rabbit IgG labeled by HRP.
The method for preparing the pichia pastoris UGGT1 polyclonal antibody comprises the following specific steps:
(1) taking a pichia pastoris genome as a template, and carrying out PCR amplification on a DNA fragment of UGGT1 gene;
(2) inserting the DNA fragment into an escherichia coli expression vector, converting the escherichia coli expression vector into escherichia coli, and obtaining a recombinant escherichia coli positive strain carrying a UGGT1 gene fragment through resistance screening and DNA sequencing; the Escherichia coli expression vector and host strain, preferably but not limited to pEASY-Blunt E2 and transetta;
(3) inducing and expressing the recombinant escherichia coli strain by IPTG, breaking the wall by ultrasonic, centrifuging and collecting precipitates to obtain an inclusion body of UGGT1 protein fragments, and dissolving the inclusion body in 8M urea to prepare UGGT1 antigen; the concentration of the IPTG is preferably but not limited to 1mM, the induction condition is preferably but not limited to 37 ℃, the rotating speed is 200rpm/min, and the induction time is 5 h;
(4) mixing the antigen with a proper immunologic adjuvant, immunizing animals for several times, and obtaining an antibody of pichia pastoris UGGT 1; the method for immunizing animals, preferably but not limited to three times, is carried out on days 0, 14 and 28 respectively.
The invention has the beneficial effects that: the UGGT1 antibody prepared by the method has high titer and good specificity, and the UGGT1 protein in the pichia pastoris can be qualitatively or quantitatively detected by adopting a conventional immunobiotechnology method, such as ELISA, Western-blot and the like, so that necessary experimental materials and technical support are provided for the functional research, glycoprotein synthesis and metabolic mechanism research of UGGT1 of pichia pastoris and other higher eukaryotes.
Drawings
FIG. 1 shows the DNA fragment PCR products of 1133-1430 amino acids of Pichia pastoris genome and UGGT1 identified by agarose gel electrophoresis;
in the figure, 1-Pichia genome; 2-UGGT1 of amino acids 1133 and 1430 of DNA fragment PCR product; 3-blank control (in ddH)2Performing PCR by taking O as a template); M-DNA Marker.
FIG. 2 is a map of an E.coli expression plasmid containing a DNA fragment of 3397-4290bp of UGGT 1; the DNA segment of UGGT1 is located between the T7 promoter and terminator of the vector.
FIG. 3 is an SDS-PAGE identification of UGGT1 expression in E.coli;
in the figure, 1-E.coli inclusion body is dissolved in 8 urea, and the molecular weight is about 33 kD; 2-soluble proteins in the Escherichia coli cells; 3-intracellular protein before IPTG induction of escherichia coli; 4-intracellular protein induced by escherichia coli IPTG; M-Protein Marker.
FIG. 4 ELISA assay of UGGT1 protein in Pichia pastoris; the UGGT1 knockout yeast strain is used as a negative control, and the absorbance value of OD405 is increased along with the increase of the wet weight of the strain.
FIG. 5 shows a Western-blot method for identifying UGGT1 protein in Pichia pastoris;
in the figure, the 1-pichia UGGT1 protein has a molecular weight, which is predicted to be about 170 kD; after the gene of 2-pichia UGGT1 is knocked out, no corresponding band exists; M-Protein Marker.
Detailed Description
In order that the invention may be more fully understood, reference will now be made to the following description. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete.
Example 1: extraction of Pichia pastoris genome and cloning of DNA fragment of 1133-1430 amino acids of UGGT1
Pichia pastoris strain GS115 was inoculated into 20mL YPD medium (1% yeast extract,2% peptone, 2% dextrose), shake-cultured at 28 ℃ and 200rpm/min to OD600Collecting thallus by centrifugation at 12000rpm/min at 0.8-1.0, washing cells twice with sterilized deionized water, adding 200. mu.L Tris/SDS buffer (0.2M Tris-HCl pH7.6, 0.5M NaCl, 0.1% (W/V) SDS, 0.01M EDTA), mixing, adding 100. mu.L Tris-equilibrated phenol and 100. mu.L chloroform, adding 50 beads of acidified glass, shaking in ice bath for 30s, adding 200. mu.L TE (pH8.0), mixing, centrifuging at 12000rpm/min for 5min, transferring the upper aqueous phase into another centrifuge tube, adding 1mL ethanol, 1/10 volume of 3M NaAc, slowly mixing, standing at-20 ℃ for 5min, 12000rpm/min, centrifuging at 4 ℃ for 5min, carefully discarding the supernatant, washing with 75% alcohol once, adding 40. mu.L TE containing RNaseA (pH8.0), dissolving, and standing at-37 ℃ for 5min and at-20 ℃ for use.
Taking 1 mu L of the Pichia pastoris genome as a template, and taking p1 and p2 as primers
p1: CTAATTGGCAATACAGCAACTACTG;p2:CTGCACTTGATCATCATACTGGGTC。
The DNA fragment of 1133-1430 amino acids of UGGT1 is amplified by PCR, and the PCR system is as follows: template 1. mu.L, 10 XTaq DNA Polymerase buffer 5. mu.L, 2.5mM dNTP 4. mu.L, p 12. mu.L, p 22. mu.L, Taq DNA Polymerase 0.5. mu.L, ddH2O 36. mu.L. The reaction conditions were as follows: pre-denaturation at 94 ℃ for 2min, denaturation at 94 ℃ for 50sec, annealing at 50 ℃ for 1min, extension at 72 ℃ for 50sec, and extension at 72 ℃ for 10min, for a total of 30 cycles.
A part of the PCR products are detected by agarose gel electrophoresis (figure 1), and after the molecular weight is correct, the PCR products are stored at-80 ℃ for later use.
Example 2: construction of recombinant Escherichia coli strain containing 3397-4290bp gene fragment of Pichia pastoris UGGT1
Taking 4 mu L of the PCR product described in example 1, mixing with 1 mu L of Escherichia coli expression vector pEASY-Blunt E2 (Beijing Omega Biotechnology Co., Ltd.), water bath at 25 ℃ for 10min, mixing the ligation product with 100 mu L of Escherichia coli expression strain transetta competent cells (Beijing Omega Biotechnology Co., Ltd.), ice-cooling for 10min, heat-shocking at 42 ℃ for 30s, adding 500 mu L of liquid LB culture medium, shaking and culturing at 37 ℃ and 200rpm/min for 1h, coating on a resistant LB plate containing 50 mu g/L ampicillin, culturing at 37 ℃ overnight, picking out single colony for sequencing, and obtaining the positive clone with correct sequencing result, namely the recombinant Escherichia coli strain containing 3397-4290bp gene fragment of Pichia pastoris UGGT1 (figure 2).
Example 3: preparation of pichia UGGT1 antigen
Inoculating the recombinant Escherichia coli strain into 5mL of liquid LB culture medium containing 50. mu.g/L ampicillin, performing shake culture at 37 ℃ overnight, taking 1mL of the liquid LB culture medium, transferring the liquid LB culture medium into 100 mL of liquid LB culture medium containing 50. mu.g/L ampicillin, and performing shake culture at 37 ℃ for about 3h to OD600=0.8-1.0, adding IPTG to a final concentration of 1mM, continuing culturing for 5h under the same conditions, centrifuging at 12000rpm/min for 1min to collect thalli, breaking the wall by ultrasonic, centrifuging at 12000rpm/min for 5min to collect precipitates, washing the precipitates with 4M urea for 2 times, dissolving the precipitates in 8M urea, storing at 4 ℃ for later use, and identifying the SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) of the antigen expressed in escherichia coli as shown in figure 3.
Example 4: preparation of Pichia pastoris UGGT1 polyclonal antibody
50 mu L of 0.2mg/mL antigen is mixed with an equal volume of complete Freund's adjuvant uniformly, the concentration of the antigen is 0.2mg/mL, 8-week-old male Kunming mice are immunized by abdominal subcutaneous injection, 14 days later, the equal volume of antigen is mixed with the incomplete Freund's adjuvant uniformly, mice are injected by abdominal subcutaneous injection, after 14 days later, the immunization is strengthened for 1 time by the same method, 7 days later, the mouse venous serum is collected, and the antiserum containing the Pichia pastoris UGGT1 polyclonal antibody is obtained and can be directly used for experiments such as ELISA, Western-blot and the like.
Example 5: ELISA (enzyme-Linked immunosorbent assay) for UGGT1 protein in pichia pastoris
Alkaline phosphatase-labeled mouse secondary antibody is purchased from Aibocai (Shanghai) trade company, yeast intracellular protein is extracted by a yeast protein extraction kit (biological engineering (Shanghai) company Limited), UGGT1 knockout yeast strain is used as a negative control, and ELISA detection results are shown in figure 4405The raised, i.e., prepared, antibody can bind to the yeast UGGT1 protein.
Example 6: western-blot identification of UGGT1 protein in pichia pastoris
The alkaline phosphatase-labeled mouse secondary antibody is purchased from Aiboc (Shanghai) trade company, a yeast protein extraction kit (biological engineering (Shanghai) corporation) is adopted for extracting the yeast intracellular protein, a yeast strain with UGGT1 gene knockout is used as a negative control, the Western-blot detection result is shown in figure 5, and the result shows that the prepared antibody can be specifically combined with yeast UGGT1 protein.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.
Sequence listing
<110> institute of biotechnology of Chinese academy of agricultural sciences
<120> a polyclonal antibody of Pichia pastoris UGGT1
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1450
<212> PRT
<213> Pichia pastoris (Pichia pastoris)
<400> 1
Met Ile Asn His Val Leu Ile Leu Leu Thr Tyr Leu Cys Leu Ser Val
1 5 10 15
Phe Ala Ser Glu Lys Phe Val Asp Ile Ser Leu Lys Ala Asn Trp Phe
20 25 30
Lys Thr Pro Phe Pro Leu Leu Leu Leu Glu Thr Val Ala Ser Glu Asn
35 40 45
Glu Ser Gly Phe Tyr Thr Ile Leu Asp Ala Met Phe Asp Val Ser Phe
50 55 60
Glu Ser Leu Glu Leu Glu Asp Glu Asp Leu Gln Phe Glu Ala Val Pro
65 70 75 80
Phe Val Lys Ser Asp Glu Glu Leu Tyr Glu Lys Trp Ser His Arg Ala
85 90 95
Gly Ala Ser Ile Glu Lys Ser Ile Thr Asp Ile Tyr Leu Ala Asn Lys
100 105 110
Tyr Tyr Ala Pro Arg Val Gln Ser His Tyr Gln His Tyr Asn Glu Val
115 120 125
Arg Ser Ser Ile Leu Gly Asp Lys Cys Gly Thr Asn Pro Lys Ala Trp
130 135 140
Leu Tyr Phe Asn Ser Glu Val Tyr Cys Asn Ser Asp Asp Val Phe Ala
145 150 155 160
Leu Lys Thr Gly Gly Lys Thr Gly Pro Pro Gln Ile Leu Pro Phe Asp
165 170 175
Arg Val Ile Gly Val Arg Asn Asp Glu Val Pro Val Ala Ile Ile Tyr
180 185 190
Gly Asp Tyr Arg Ser Pro Leu Phe Ser Gln Phe Ile Ser Asn Leu Ala
195 200 205
Gly Phe Val Lys Asp Gly Arg Leu Arg Leu Ala Trp Arg Tyr Ile Ser
210 215 220
Asp Glu Ser Val Leu Gln Lys Glu Thr Leu Ala Gly Tyr Gly Val Asp
225 230 235 240
Leu Thr Leu Lys Arg Thr Asp Tyr Ile Val Ile Asp Asp Arg Asp Ile
245 250 255
Val Leu Asp Lys Ser Leu Glu Thr Lys Pro Ile Ala Ala Glu Ser Asp
260 265 270
Asn Phe Trp Asp Val Tyr Ser Lys Glu Ile Glu Pro Val Ser Glu Lys
275 280 285
Tyr Ile Arg Ala Leu Gly Tyr Lys Leu Ser Leu Tyr Ile Lys Ser Leu
290 295 300
Glu Val Ser Glu Asn Glu Lys Leu Ala Ile Leu Thr Lys Leu Ile Gln
305 310 315 320
Asp Phe Pro Lys Phe Ala Ser Phe Ile Asp Arg Gln Val Thr Asp Thr
325 330 335
Glu Val Glu Glu Ile Ile Glu Asp Ser Leu Glu Asn Ser Ile Asn Asp
340 345 350
Leu Pro Gln Gly Val Tyr Ile Asn Gly Ala Val Val Asp Gln Ser Lys
355 360 365
Leu Asn Tyr Met Glu Ile Leu Asn Ile Leu Lys Arg Glu Tyr Ala Phe
370 375 380
Ile Asp Asp Ile Thr Lys Phe Gly Val Thr Gly Thr His Ala Gln Asp
385 390 395 400
Ile Met Arg Arg Phe Ala Ala His Ile Ser Asp Arg Ser Val Asn Asn
405 410 415
Thr Met Phe Lys Arg Phe Asp Ile Arg Gly His Gly Glu Ala Val Phe
420 425 430
Tyr Leu Asn Asp Ile Glu Thr Asp Pro Gln Tyr Ser Gly Leu Ser Ser
435 440 445
Ser Arg Lys Tyr Tyr Thr Thr Ser Val Ala Pro Gly Glu Ile Pro Pro
450 455 460
Val Arg Glu Asn Ile His Glu Ser Val Phe Val Ile Asp Leu Ala Asp
465 470 475 480
His Asn Gln Val Tyr Thr Leu Leu Gln Phe Ser Ser Val Met Leu Ser
485 490 495
Asn Arg Ile Pro Gln Arg Val Gly Phe Val Pro Leu Ile Ser Asp Lys
500 505 510
Leu Ser Glu Glu Ile Thr Leu Gln Phe Leu Ser Ile Phe Gln Ala Lys
515 520 525
Gly Ile Asn Gln Gly Ile Lys Tyr Leu His Asp Ile Ala Met Asn Val
530 535 540
Leu Gly Gln Thr Pro Arg Asp Ile Ile Ser Val Glu Ser Ile Thr Lys
545 550 555 560
Val Pro Val Ser Asp Lys Lys Asn Leu Leu Ser Lys Ile Asn Glu Phe
565 570 575
Ile Ser Ser Phe Ser Ile Asp His Pro Leu Leu Ile Thr Asn Gly Lys
580 585 590
Phe Phe Asp Phe Val Gln Asn Trp Gln Tyr His Ser Ala Arg Glu Ile
595 600 605
Phe Leu Asp Ile Leu Asp Leu Ser Asn Ala Ile Ser Ser Gly Ala Leu
610 615 620
Ser Glu Asp Met Arg Ala Gln Asp Tyr Ile Tyr Leu Gly Ser His Thr
625 630 635 640
Ser Arg Asn Val Leu Ile Ile Asn Ala Ile Cys Glu Glu Thr Asn Leu
645 650 655
Pro Ser Leu Val Ser Tyr Asp Asp Leu Glu Val Phe Glu Ser Ile Ser
660 665 670
Gln Asn Gln Asn Arg Ile Ala Thr Val Val Ile Asp Gly Gln Pro Asp
675 680 685
Ser Ile Pro Ile Thr Ser Trp Leu Leu Gly Asn Cys Lys Asp Lys Arg
690 695 700
Phe Leu Gln Gln Leu Arg His Leu Ile Thr Ala Ala Ser Glu Leu Asp
705 710 715 720
Pro Ile Lys Ile Lys Val Tyr Glu Thr Ser Ser Asn Ser Asp Phe Ser
725 730 735
Ser Ser Leu Gln Thr Ala Ile Asn Lys Ser Leu Val Asp Val Ile Ala
740 745 750
Phe Ile Asp Asn Glu Leu Glu Lys Ile Asn Val His Ser Pro Asp Thr
755 760 765
Val Leu Asn Asp Glu Thr Ile Asp Phe Val His Asn Val Phe Lys Ile
770 775 780
Lys Leu Ser Lys Pro Asn Asp Met Tyr Leu Ile Leu Asn Gly Arg Ala
785 790 795 800
Ile Lys Ile Arg Asp Lys Asp Ile Leu Leu Lys Asp Thr Asp Leu Lys
805 810 815
Leu Leu Val Glu Tyr Glu Ile Asp Phe Lys Leu Arg Ile Ala His Glu
820 825 830
Leu Phe Cys Glu Tyr Asn Ile Ser Glu Pro Lys Ser Leu Asp Thr Phe
835 840 845
Glu Leu Phe Glu Tyr Phe Thr Met Gly Ile Ser Asn Thr Tyr Phe Phe
850 855 860
Gly Asp Asn Tyr His Pro Asp Gln Arg Val Phe Pro Arg Tyr Asn Thr
865 870 875 880
Gly Leu Leu Asn Asp Ala Val Ser Ile Glu Val Ser Asn Ser Gly Pro
885 890 895
Ser Ile Met Asp Val Thr Val Ile Ile Asp Pro Leu Gln Glu Glu Ser
900 905 910
Gln Lys Leu Ile Ser Leu Leu Ser Leu Phe Glu Lys Leu Glu Ser Leu
915 920 925
Lys Leu Asn Ile Ile Leu Lys Pro Gln Glu Ala Arg Glu Leu Asn Ile
930 935 940
Lys Arg Phe Tyr Arg Gly Val Phe Pro Asn Ser Val Lys Phe Ser Ser
945 950 955 960
Ala Gly Asp Ala Ile Asp Asn Glu Asp Lys Gly Leu Phe Thr Leu Val
965 970 975
Pro Glu Lys Thr Leu Phe Thr Leu Asp Leu Asp Val Pro Asn Pro Trp
980 985 990
Ile Val Val Ile Lys Glu Ala Ala Thr Asp Leu Asp Asn Val Leu Leu
995 1000 1005
Glu Asn Ser Gly Asp Val Thr Gly Val Tyr Glu Leu Lys Ser Leu Leu
1010 1015 1020
Val Glu Gly Tyr Ala Leu Glu Lys Asn Thr Lys Tyr Pro Pro Val Ala
1025 1030 1035 1040
Leu Pro Ile Glu Leu Val Gly His Ser Asp Thr Ser Ile Met Ala Asn
1045 1050 1055
Tyr Gly Tyr Phe Gln Leu Gln Ala Asn Pro Gly Leu Trp Lys Phe Val
1060 1065 1070
Val Lys Pro His Thr Arg Gly Ser Asp Ile Tyr Arg Leu Ala Asn Val
1075 1080 1085
Thr Ser Lys Ser Asn Gly Asp Thr Leu Gln Tyr Thr Ile Ile Asp Glu
1090 1095 1100
Thr Ala Ile Ile Phe Val Leu Asp Met Asn Gly Asn Val Ile Leu Pro
1105 1110 1115 1120
Val Phe Asp Arg Lys Pro Gly Gln Glu Asn Ala Ser Leu Ile Gly Asn
1125 1130 1135
Thr Ala Thr Thr Glu Lys Asp Thr Gly Leu Ser Lys Phe Leu Ser Ser
1140 1145 1150
Trp Arg Lys Gln Glu Gln Pro Lys Asn Ala Asp Ile Asn Ile Phe Thr
1155 1160 1165
Val Ala Ser Gly His Leu Tyr Glu Arg Phe Leu Ser Ile Met Thr Asn
1170 1175 1180
Ser Val Met Lys His Thr Lys His Thr Val Lys Phe Trp Leu Ile Glu
1185 1190 1195 1200
Asn Tyr Met Ser Pro Thr Phe Lys Lys Asn Leu Pro Phe Leu Ala Arg
1205 1210 1215
Glu Phe Gly Phe Asp Tyr Glu Leu Val Asn Tyr Lys Trp Pro Ala Trp
1220 1225 1230
Leu Arg Gly Gln Arg Glu Lys Gln Arg Thr Ile Trp Gly Tyr Lys Ile
1235 1240 1245
Leu Phe Leu Asp Val Leu Phe Pro Gln Ser Leu Asp Lys Val Ile Phe
1250 1255 1260
Val Asp Ala Asp Gln Ile Val Arg Thr Asp Leu Lys Glu Leu Val Asp
1265 1270 1275 1280
Leu Asp Leu Glu Gly Ala Pro Tyr Gly Tyr Thr Pro Met Cys Asn Asp
1285 1290 1295
Arg Glu Glu Met Glu Gly Phe Arg Phe Trp Lys Gln Gly Tyr Trp Gln
1300 1305 1310
Lys Leu Leu Gly Asp Thr Leu Lys Tyr His Ile Ser Ala Leu Tyr Val
1315 1320 1325
Ile Asp Leu Lys Thr Phe Arg Gln Ile Ala Ala Gly Asp Arg Leu Arg
1330 1335 1340
Gln His Tyr Gln Gln Leu Ser Gln Asp Pro Asn Ser Leu Ser Asn Leu
1345 1350 1355 1360
Asp Gln Asp Leu Pro Asn Asn Leu Gln His Gln Ile Lys Ile Phe Ser
1365 1370 1375
Leu Pro Gln Glu Trp Leu Trp Cys Glu Thr Trp Cys Ser Asp Glu Ser
1380 1385 1390
Leu Lys Lys Ala Lys Thr Ile Asp Leu Cys Asn Asn Pro Leu Thr Lys
1395 1400 1405
Glu Pro Lys Leu Asp Arg Ala Arg Arg Gln Ile Pro Glu Trp Thr Gln
1410 1415 1420
Tyr Asp Asp Gln Val Gln Gln Ile Ile Asn Glu Ala Ser Ala Ser Ala
1425 1430 1435 1440
Arg Glu Ser Ile Thr Glu His Asp Glu Leu
1445 1450
<210> 2
<211> 4353
<212> DNA
<213> Pichia pastoris (Pichia pastoris)
<400> 2
atgattaatc atgtcttaat attgttgaca tacttatgtc tgtccgtgtt tgcatctgaa 60
aagtttgttg atatcagttt gaaggccaat tggttcaaaa ctcctttccc actgttacta 120
ctggagacag ttgcaagtga gaatgaatca ggcttttaca caatacttga cgccatgttt 180
gacgtctcat ttgaatcttt agagctagaa gatgaagatt tgcaatttga agctgttcct 240
tttgttaaat ctgatgaaga attgtacgaa aaatggtctc atagggctgg ggcatcgatt 300
gaaaagtcga taactgatat atatcttgca aacaagtact atgctccaag ggttcaatca 360
cattaccagc actacaatga agttcggtcc tcaattttag gtgacaagtg tggaactaat 420
cctaaggcgt ggctctattt caatagtgaa gtatactgca actccgatga tgtcttcgca 480
ttgaaaactg gcggcaagac gggcccacca caaatcctgc cattcgatag agtcattggt 540
gtcagaaatg atgaagttcc tgttgcaatt atttatgggg attatagaag ccctcttttt 600
tcacagttta tctctaactt ggcgggattc gtcaaagatg gtagactgag attagcttgg 660
aggtatattt ctgacgaatc cgttttgcaa aaagaaactc tagctgggta tggtgttgat 720
ctaactttaa agagaactga ctatattgtt attgacgaca gagatatagt tcttgacaaa 780
tcattagaaa caaagcccat tgcggctgaa tccgataact tttgggatgt ttactccaaa 840
gagattgagc ctgtatctga gaaatacatt agggcattgg gttacaaact ttcactttat 900
atcaagagcc ttgaagtgtc cgagaacgaa aagttggcaa ttctcactaa gttgatccaa 960
gacttcccaa agtttgcatc tttcattgat cgtcaggtaa cggatactga agtggaggag 1020
atcattgagg atagtttgga aaactcaatt aatgatttac ctcagggtgt gtatattaac 1080
ggggctgtag ttgaccaatc caagttaaat tatatggaga tcttgaatat tttgaagaga 1140
gaatatgcat tcatcgatga cataaccaag ttcggagtta caggaaccca tgcacaggat 1200
atcatgaggc gttttgctgc tcacatttcc gataggtcag ttaacaacac tatgttcaag 1260
agatttgata ttagaggcca tggagaagct gttttttact tgaatgatat cgaaactgat 1320
cctcaatatt ctggactttc aagctctaga aaatattata cgacatcagt tgctccaggt 1380
gagattcccc ctgtgagaga gaacattcac gaatcagtgt tcgtcataga tctagcagat 1440
cataatcagg tttacacgtt gctacaattt tcatctgtaa tgctttctaa caggatacca 1500
caaagagtgg gctttgttcc acttatttct gataagttaa gtgaagagat tactttgcag 1560
tttttatcca tctttcaagc taagggcata aaccagggaa taaaatactt gcatgatatt 1620
gccatgaatg tcttaggaca gactccaagg gatataattt ccgttgaatc gatcactaag 1680
gtccctgttt ctgataagaa aaatctgctt tccaaaatca acgagttcat cagttccttt 1740
tcaattgacc acccactact tattacgaat ggtaagtttt ttgatttcgt gcagaactgg 1800
cagtatcatt ccgctagaga gatatttctg gacatacttg acctgagcaa tgcgatctcc 1860
agcggtgcac tttctgaaga tatgagagcc caagactaca tttaccttgg atctcacact 1920
tctaggaatg tccttatcat aaatgcaatt tgtgaagaaa ccaaccttcc atcccttgtt 1980
tcttatgatg atttagaagt cttcgaatca atttcacaga accaaaatcg gattgccaca 2040
gttgtcatag atggccaacc agattcgatc ccaattacgt cctggttact aggaaactgc 2100
aaggataaaa ggtttttgca gcagctccgt catttgataa ctgctgcatc tgagttggac 2160
cctatcaaga tcaaagtcta cgaaacttct tcaaactctg atttttcatc gagcctacag 2220
acagccataa acaagtcttt ggtggatgtg atagcgttca ttgataacga acttgaaaaa 2280
atcaatgtgc attccccaga caccgtattg aacgacgaaa ccatagattt tgtccacaat 2340
gttttcaaaa tcaagctctc caaaccaaat gatatgtact taattcttaa tggaagggct 2400
attaagatta gagataagga catattactg aaagacactg atctcaaact gctagttgaa 2460
tacgaaatag atttcaagtt gagaatcgct catgaactgt tttgcgagta caacatctct 2520
gaacccaaga gtttggatac ttttgaattg tttgagtatt tcactatggg catctccaat 2580
acatacttct ttggtgacaa ttatcaccca gatcaacggg tattcccaag atataatact 2640
ggccttctca atgatgcagt ctccattgaa gtttcaaact ctgggccatc tatcatggat 2700
gtgaccgtga tcatagatcc tcttcaagaa gagtctcaaa agctaatatc gttgctctcg 2760
ttgtttgaaa aattggaaag ccttaagctt aacattatcc tgaaaccaca agaagctagg 2820
gagttaaaca ttaaacgatt ttatcgtgga gtatttccta attcagtgaa attttcctcc 2880
gcaggagatg ctattgataa tgaagataaa ggccttttca cactggtacc agaaaaaacc 2940
ttgtttacat tagacttgga cgttcctaac ccgtggattg ttgtgattaa ggaagctgcc 3000
accgatttgg ataatgtact attggaaaat tcaggtgatg tgacaggtgt ctatgagctg 3060
aaatcgcttc tagttgaagg gtatgcactt gagaagaaca caaaatatcc acctgtagct 3120
ttacccatag agcttgtggg acattccgac acaagtatta tggccaatta tggatatttc 3180
caattgcaag cgaacccagg attgtggaaa tttgttgtca agccccatac taggggctca 3240
gatatctatc gattggcgaa cgttacaagt aagtctaacg gtgatacact tcagtacacc 3300
attattgacg agactgctat aatctttgtc ttggatatga atggaaatgt tattctgcct 3360
gtgtttgaca ggaaacctgg ccaagagaat gcatctctaa ttggcaatac agcaactact 3420
gaaaaagata caggcctcag caaatttttg tcttcatggc gaaaacaaga acaaccgaag 3480
aatgctgata tcaacatttt cacagttgct agtgggcatc tatatgagcg attcttgtca 3540
ataatgacaa actctgtaat gaagcacacc aagcataccg tcaagttttg gctaattgag 3600
aactacatgt cacccacgtt caagaagaat ttacccttcc ttgcccgaga gtttgggttt 3660
gactatgaac tggtcaacta taagtggcca gcatggctga ggggtcaaag ggagaaacaa 3720
cgaactatct ggggatataa gattttgttc ttggatgttt tgttccctca aagcctcgat 3780
aaagtgatat ttgttgacgc ggaccaaata gttagaacag atctaaagga gcttgtggat 3840
ttggaccttg aaggtgcgcc ttatggatat actccaatgt gcaacgacag ggaagagatg 3900
gaagggttta gattttggaa acagggatat tggcagaagc tcttgggtga tactctaaag 3960
tatcacatca gtgccctgta cgtgattgac ttgaaaactt ttaggcagat tgctgccggt 4020
gataggttga gacaacacta ccagcaactt tctcaagatc caaattcttt gtcaaaccta 4080
gatcaagatc taccaaataa tcttcagcac caaatcaaaa ttttttcact ccctcaagag 4140
tggctgtggt gtgaaacttg gtgtagcgat gagagtttaa agaaggcaaa gacgatagac 4200
ctttgcaaca accctttaac caaggaacca aaattagaca gagcacgaag acaaattcca 4260
gaatggaccc agtatgatga tcaagtgcag caaattataa acgaagcatc tgcaagcgct 4320
agggaatcca tcactgaaca tgatgagctt tag 4353
<210> 3
<211> 298
<212> PRT
<213> Pichia pastoris (Pichia pastoris)
<400> 3
Leu Ile Gly Asn Thr Ala Thr Thr Glu Lys Asp Thr Gly Leu Ser Lys
1 5 10 15
Phe Leu Ser Ser Trp Arg Lys Gln Glu Gln Pro Lys Asn Ala Asp Ile
20 25 30
Asn Ile Phe Thr Val Ala Ser Gly His Leu Tyr Glu Arg Phe Leu Ser
35 40 45
Ile Met Thr Asn Ser Val Met Lys His Thr Lys His Thr Val Lys Phe
50 55 60
Trp Leu Ile Glu Asn Tyr Met Ser Pro Thr Phe Lys Lys Asn Leu Pro
65 70 75 80
Phe Leu Ala Arg Glu Phe Gly Phe Asp Tyr Glu Leu Val Asn Tyr Lys
85 90 95
Trp Pro Ala Trp Leu Arg Gly Gln Arg Glu Lys Gln Arg Thr Ile Trp
100 105 110
Gly Tyr Lys Ile Leu Phe Leu Asp Val Leu Phe Pro Gln Ser Leu Asp
115 120 125
Lys Val Ile Phe Val Asp Ala Asp Gln Ile Val Arg Thr Asp Leu Lys
130 135 140
Glu Leu Val Asp Leu Asp Leu Glu Gly Ala Pro Tyr Gly Tyr Thr Pro
145 150 155 160
Met Cys Asn Asp Arg Glu Glu Met Glu Gly Phe Arg Phe Trp Lys Gln
165 170 175
Gly Tyr Trp Gln Lys Leu Leu Gly Asp Thr Leu Lys Tyr His Ile Ser
180 185 190
Ala Leu Tyr Val Ile Asp Leu Lys Thr Phe Arg Gln Ile Ala Ala Gly
195 200 205
Asp Arg Leu Arg Gln His Tyr Gln Gln Leu Ser Gln Asp Pro Asn Ser
210 215 220
Leu Ser Asn Leu Asp Gln Asp Leu Pro Asn Asn Leu Gln His Gln Ile
225 230 235 240
Lys Ile Phe Ser Leu Pro Gln Glu Trp Leu Trp Cys Glu Thr Trp Cys
245 250 255
Ser Asp Glu Ser Leu Lys Lys Ala Lys Thr Ile Asp Leu Cys Asn Asn
260 265 270
Pro Leu Thr Lys Glu Pro Lys Leu Asp Arg Ala Arg Arg Gln Ile Pro
275 280 285
Glu Trp Thr Gln Tyr Asp Asp Gln Val Gln
290 295
<210> 4
<211> 894
<212> DNA
<213> Pichia pastoris (Pichia pastoris)
<400> 4
ctaattggca atacagcaac tactgaaaaa gatacaggcc tcagcaaatt tttgtcttca 60
tggcgaaaac aagaacaacc gaagaatgct gatatcaaca ttttcacagt tgctagtggg 120
catctatatg agcgattctt gtcaataatg acaaactctg taatgaagca caccaagcat 180
accgtcaagt tttggctaat tgagaactac atgtcaccca cgttcaagaa gaatttaccc 240
ttccttgccc gagagtttgg gtttgactat gaactggtca actataagtg gccagcatgg 300
ctgaggggtc aaagggagaa acaacgaact atctggggat ataagatttt gttcttggat 360
gttttgttcc ctcaaagcct cgataaagtg atatttgttg acgcggacca aatagttaga 420
acagatctaa aggagcttgt ggatttggac cttgaaggtg cgccttatgg atatactcca 480
atgtgcaacg acagggaaga gatggaaggg tttagatttt ggaaacaggg atattggcag 540
aagctcttgg gtgatactct aaagtatcac atcagtgccc tgtacgtgat tgacttgaaa 600
acttttaggc agattgctgc cggtgatagg ttgagacaac actaccagca actttctcaa 660
gatccaaatt ctttgtcaaa cctagatcaa gatctaccaa ataatcttca gcaccaaatc 720
aaaatttttt cactccctca agagtggctg tggtgtgaaa cttggtgtag cgatgagagt 780
ttaaagaagg caaagacgat agacctttgc aacaaccctt taaccaagga accaaaatta 840
gacagagcac gaagacaaat tccagaatgg acccagtatg atgatcaagt gcag 894

Claims (4)

1. A polyclonal antibody of Pichia pastoris UGGT1 is characterized in that the antibody is a polyclonal antibody prepared by animal immunization with amino acid sequence polypeptide at 1133-1430 th site of Pichia pastoris UGGT1 as antigen.
2. The polyclonal antibody of the Pichia pastoris UGGT1 according to claim 1, wherein the antigen is the polypeptide of amino acid sequence at 1133-1430 of Pichia pastoris UGGT1 as core sequence, and more amino acid residues or less amino acid residues are added at two ends or one end of the polypeptide.
3. A kit for detecting pichia pastoris UGGT1 protein, comprising the polyclonal antibody of claim 1 or 2.
4. An indirect sandwich ELISA detection kit for Pichia pastoris UGGT1 protein, which is characterized by comprising Pichia pastoris UGGT1 standard protein, washing liquid, confining liquid, substrate developing liquid, stopping liquid, an ELISA plate coated with the polyclonal antibody of claim 1 or 2, a detection antibody and an enzyme labeled antibody; the enzyme-labeled antibody is goat anti-rabbit IgG labeled by HRP.
CN202110020699.8A 2021-01-08 2021-01-08 Polyclonal antibody of pichia pastoris UGGT1 Pending CN112375143A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110020699.8A CN112375143A (en) 2021-01-08 2021-01-08 Polyclonal antibody of pichia pastoris UGGT1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110020699.8A CN112375143A (en) 2021-01-08 2021-01-08 Polyclonal antibody of pichia pastoris UGGT1

Publications (1)

Publication Number Publication Date
CN112375143A true CN112375143A (en) 2021-02-19

Family

ID=74590216

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110020699.8A Pending CN112375143A (en) 2021-01-08 2021-01-08 Polyclonal antibody of pichia pastoris UGGT1

Country Status (1)

Country Link
CN (1) CN112375143A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
CN1302895A (en) * 1999-11-02 2001-07-11 上海生元基因开发有限公司 Human UDP glucose-glycoprotein glycosyl transferase and itscoding sequence
WO2002022660A2 (en) * 2000-09-11 2002-03-21 Hyseq, Inc. Novel nucleic acids and polypeptides
US6399321B1 (en) * 1999-08-18 2002-06-04 National Research Council Of Canada Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
US6399321B1 (en) * 1999-08-18 2002-06-04 National Research Council Of Canada Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT
CN1302895A (en) * 1999-11-02 2001-07-11 上海生元基因开发有限公司 Human UDP glucose-glycoprotein glycosyl transferase and itscoding sequence
WO2002022660A2 (en) * 2000-09-11 2002-03-21 Hyseq, Inc. Novel nucleic acids and polypeptides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DE SCHUTTER,K.,等: "《Protein required for beta-1,6 glucan biosynthesis [Komagataella phaffii GS115]》", 《NCBI REFERENCE SEQUENCE: XP_002493168.1》 *
KRISTOF DE SCHUTTER等: "《Genome sequence of the recombinant protein production host Pichia pastoris》", 《NAT. BIOTECHNOL.》 *
NO REPORTED: "《MBS2000257 96 tests enzyme-linked immunosorbent assay kit for UDP-glucose glycoprotein glucosyltransferase1(UGGT1)organism species:Homo sapiens(human)instruction manual》", 《INSTRUCTION MANUAL》 *

Similar Documents

Publication Publication Date Title
Sundstrom Adhesion in Candida spp
JP3406314B2 (en) Trans destabilization of specific proteins in vivo
CN109078178B (en) Clostridium perfringens β toxin recombinant subunit vaccine and production method thereof
CN104725517B (en) A kind of method for improving yeast cell surface destination protein displaying amount
CN101302526A (en) Recombinant soluble streptococcus hemolyticus haemolysin O gene, recombinant protein and preparation thereof
JP2003527100A (en) protein
CN108314718B (en) Housefly antibacterial peptide MAF-1A peptide polymer, encoding gene thereof, expression and application thereof
CN103725697B (en) The surface protein FnBPA genetic fragment of the staphylococcus aureus of chemosynthesis and expression, application
CN112592395A (en) Construction, preparation and application of plasmodium falciparum RIFIN recombinant protein PfRIFIN-54
CN112375143A (en) Polyclonal antibody of pichia pastoris UGGT1
KR101765394B1 (en) Epitope protein of PEDV, Recombinant vector contaning genes encoding thereof, Transformnant expressing thereof, and Composition for preventing or treating PEDV comprising thereof
CN102675433A (en) Recombinant protein of methicillin-resistant staphylococcus aureus IsdB protein active segment, preparation method thereof and application thereof
CN113502294B (en) Preparation method of novel coronavirus RBD protein and novel coronavirus vaccine
CN110950968B (en) gp 96-hog cholera E2 fusion protein, preparation method thereof and vaccine
CN111925433A (en) Outizua erythropolis IFN alpha protein clone expression and polyclonal antibody preparation
CN109021099B (en) Nano antibody for specifically recognizing type 1 duck hepatitis A virus
CN104152477A (en) Schistosoma japonicum recombinant antigen SjPDI (schistosoma japonicum protein disulfide isomerase) and preparation method and application thereof
US8435537B2 (en) System for the expression of peptides on the bacterial surface
CN110041410A (en) Transmissible gastro-enteritis virus novel gene engineering subunit vaccine
CN110484556A (en) A kind of instantaneous silent carrier of Atg5 alleviates the purposes of organelle positioning protein degradation
CN116375851B (en) Nanometer antibody of anti-avian influenza virus NP protein, preparation method and application thereof
CN110484557A (en) A kind of instantaneous silent carrier of Atg5
CN109112152A (en) The recombinant bacterium of ETX-CSA and the production method of related vaccines are expressed simultaneously
CN113603758B (en) Spodoptera littoralis SoxC gene, encoding protein, vector, strain and application thereof
CN104711288A (en) Recombinant vector, recombinant baculovirus prepared from the same and application of virus in preparation of malaria vaccines

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination